Lyon, June 24, 2026 – NETRI, a French TechBio company specializing in organ-on-chip technologies combined with artificial intelligence and predictive biological models, announces its integration into the 3DEXPERIENCE Lab, the innovation program of Dassault Systems. This strategic collaboration marks a key milestone in NETRI’s industrial structuring, with the objective of digitalizing and securing its entire production chain and biological platform. By leveraging the 3DEXPERIENCE platform, NETRI aims to accelerate the scaling of both its devices and biological platform, enhancing reproducibility, traceability, and quality for the pharmaceutical, chemical, and cosmetics industries.
Leveraging the natural ability of neurons to encode biological interactions into electrical signals, NETRI’s platforms act as data generators for its digital libraries of tested and reference compound signatures, paving the way for more predictive models to assess the efficacy and safety of drug candidates and ingredients. In this context, transitioning to industrial-scale production represents a major challenge. NETRI positions itself as an integrated platform combining expertise in organ-on-chip design, advanced human cell culture, and data analysis through proprietary AI-driven software. Joining the 3DEXPERIENCE Lab is fully aligned with this ambition, enabling the structuring of a scalable, standardized, and industry-compliant production of both devices and biological processes.
